The most recent recommendations for "deep blocks" and thromboprophylaxis: evidence not supporting a "thromboprophylaxis therapeutic window".
Chelly
Jacques E
JE
D019317:Evidence-Based Medicine; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006470:Hemorrhage / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D009407:Nerve Block / Q000009:adverse effects; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D012955:Societies, Medical; D015912:Thrombolytic Therapy / Q000009:adverse effects; D014481:United States; D054556:Venous Thromboembolism / Q000517:prevention & control*
D005343:Fibrinolytic Agents